FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Rex

Research Profile

Chemicals & Drugs

Procedures

Microbial Sensitivity Tests

Living Beings

Disorders

Physiology

Co-author Network

Publications

TOP 3
John H Rex; Wendy R Sanhai; John Tomayko; Charles Knirsch; Cindy Lancaster; Robert Meyer; Jeff Alder; Aaron Dane; Barry I Eisenstein; Ian Friedland; Mark Goldberger; Jennifer Jackson
A comprehensive regulatory framework to address the unmet need for new antibacterial treatments.
A M L Oude Lashof; Peter G Pappas; John H Rex; M Ruhnke; Haran T Schlamm; Jack D Sobel; C Viscoli; Bart Jan Kullberg
Safety and tolerability of voriconazole in patients with baseline renal insufficiency and candidemia.
John F Mohr; Charles Sims; Victor L Paetznick; Jose Rodriguez; Malcolm A Finkelman; John H Rex; Luis Ostrosky-Zeichner
Prospective survey of (1→3)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Rex (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: John H Rex; Wendy R Sanhai; John Tomayko; Charles Knirsch; Cindy Lancaster; Robert Meyer; Jeff Alder; Aaron Dane; Barry I Eisenstein; Ian Friedland; Mark Goldberger; Jennifer Jackson
A comprehensive regulatory framework to address the unmet need for new antibacterial treatments.
The Lancet infectious diseases 2013;13(3):269-75.
2012: A M L Oude Lashof; Peter G Pappas; John H Rex; M Ruhnke; Haran T Schlamm; Jack D Sobel; C Viscoli; Bart Jan Kullberg
Safety and tolerability of voriconazole in patients with baseline renal insufficiency and candidemia.
Antimicrobial agents and chemotherapy 2012;56(6):3133-7.
2011: John F Mohr; Charles Sims; Victor L Paetznick; Jose Rodriguez; Malcolm A Finkelman; John H Rex; Luis Ostrosky-Zeichner
Prospective survey of (1→3)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting.
Journal of clinical microbiology 2011;49(1):58-61.
2010: Luis Ostrosky-Zeichner; Arturo Casadevall; John N Galgiani; Frank C Odds; John H Rex
An insight into the antifungal pipeline: selected new molecules and beyond.
Nature reviews. Drug discovery 2010;9(9):719-27.
2010: Zekaver Odabasi; Victor L Paetznick; Jose R Rodriguez; Enuo Chen; John H Rex; Gerhard J Leitz; Luis Ostrosky-Zeichner
Lack of correlation of 24- vs. 48-h itraconazole minimum inhibitory concentrations with microbiological and survival outcomes in a guinea pig model of disseminated candidiasis.
Mycoses 2010;53(5):438-42.
2009: Michael A Pfaller; Daniel J Diekema; Mahmoud A Ghannoum; John H Rex; B D Alexander; D Andes; S D Brown; V Chaturvedi; Ana Espinel-Ingroff; C L Fowler; E M Johnson; Cindy C Knapp; M R Motyl; L Ostrosky-Zeichner; D J Sheehan; THOMAS WALSH
Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods.
Journal of clinical microbiology 2009;47(10):3142-6.
2009: Peter G Pappas; Carol A Kauffman; David Andes; Daniel K Benjamin; Thierry F Calandra; John Edwards; Scott Filler; John F Fisher; Bart Jan Kullberg; Luis Ostrosky-Zeichner; Annette C Reboli; John H Rex; THOMAS WALSH; Jack D Sobel
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(5):503-35.
2008: Luis Ostrosky-Zeichner; John H Rex; Michael A Pfaller; Daniel J Diekema; Barbara D Alexander; David Andes; Steven D Brown; Vishnu Chaturvedi; Mahmoud A Ghannoum; Cindy C Knapp; Daniel J Sheehan; THOMAS WALSH
Rationale for reading fluconazole MICs at 24 hours rather than 48 hours when testing Candida spp. by the CLSI M27-A2 standard method.
Antimicrobial agents and chemotherapy 2008;52(11):4175-7.
2008: Michael A Pfaller; Daniel J Diekema; L Ostrosky-Zeichner; John H Rex; B D Alexander; D Andes; S D Brown; V Chaturvedi; Mahmoud A Ghannoum; Cindy C Knapp; D J Sheehan; THOMAS WALSH
Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints.
Journal of clinical microbiology 2008;46(8):2620-9.
2007: Zekaver Odabasi; Victor L Paetznick; John H Rex; Luis Ostrosky-Zeichner
Effects of serum on in vitro susceptibility testing of echinocandins.
Antimicrobial agents and chemotherapy 2007;51(11):4214-6.
2007: Luis Ostrosky-Zeichner; C Sable; Jack D Sobel; Barbara D Alexander; Gerald R Donowitz; V Kan; Carol A Kauffman; Daniel H Kett; Robert A Larsen; V Morrison; M Nucci; Peter G Pappas; M E Bradley; S Major; L Zimmer; D Wallace; William E Dismukes; John H Rex
Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2007;26(4):271-6.
2006: Michael A Pfaller; Daniel J Diekema; John H Rex; Ana Espinel-Ingroff; E M Johnson; D Andes; V Chaturvedi; Mahmoud A Ghannoum; F C Odds; Michael G Rinaldi; Daniel J Sheehan; P Troke; THOMAS WALSH; D W Warnock
Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints.
Journal of clinical microbiology 2006;44(3):819-26.
2005: Charles R Sims; Luis Ostrosky-Zeichner; John H Rex
Invasive candidiasis in immunocompromised hospitalized patients.
Archives of medical research 2005;36(6):660-71.
2005: Luis Ostrosky-Zeichner; D Kontoyiannis; J Raffalli; K M Mullane; Jose A Vazquez; Elias J Anaissie; J Lipton; P Jacobs; J H Jansen van Rensburg; John H Rex; W Lau; David P Facklam; Donald N Buell
International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2005;24(10):654-61.
2005: Annie Philip; Zekaver Odabasi; Gloria Matiuzzi; Victor L Paetznick; Sze-wee Tan; John Warmington; John H Rex; Luis Ostrosky-Zeichner
Syscan3, a kit for detection of anti-Candida antibodies for diagnosis of invasive candidiasis.
Journal of clinical microbiology 2005;43(9):4834-5.
2005: Luis Ostrosky-Zeichner; Barbara D Alexander; Daniel H Kett; Jose A Vazquez; Peter G Pappas; Fumihiro Saeki; Paul A Ketchum; John Wingard; Robert Schiff; Hiroshi Tamura; Malcolm A Finkelman; John H Rex
Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(5):654-9.
2005: Annie Philip; Zekaver Odabasi; Jose Rodriguez; Victor L Paetznick; Enuo Chen; John H Rex; Luis Ostrosky-Zeichner
In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp.
Antimicrobial agents and chemotherapy 2005;49(8):3572-4.
2005: M Cecilia Dignani; John H Rex; Ka-Wah Chan; Gordon Dow; Margarida deMagalhaes-Silverman; AnneMarie Maddox; THOMAS WALSH; Elias Anaissie
Immunomodulation with interferon-gamma and colony-stimulating factors for refractory fungal infections in patients with leukemia.
Cancer 2005;104(1):199-204.
2005: Niki I Paphitou; Luis Ostrosky-Zeichner; John H Rex
Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2005;43(3):235-43.
2004: Banu Sancak; John H Rex; Enuo Chen; Kieren Marr
Comparison of PCR- and HinfI restriction endonuclease-based methods for typing of Candida krusei isolates.
Journal of clinical microbiology 2004;42(12):5889-91.
2004: John F Mohr; Kevin W Finkel; John H Rex; Jose R Rodriguez; Gerhard J Leitz; Luis Ostrosky-Zeichner
Pharmacokinetics of intravenous itraconazole in stable hemodialysis patients.
Antimicrobial agents and chemotherapy 2004;48(8):3151-3.
2004: Zekaver Odabasi; Gloria N Mattiuzzi; Elihu Estey; Andrew Lamb; Fumihiro Saeki; Richard J Ridge; Paul A Ketchum; Malcolm A Finkelman; John H Rex; Luis Ostrosky-Zeichner
Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(2):199-205.
2004: Michael A Pfaller; Daniel J Sheehan; John H Rex
Determination of fungicidal activities against yeasts and molds: lessons learned from bactericidal testing and the need for standardization.
Clinical microbiology reviews 2004;17(2):268-80.
2004: John F Mohr; Audrey Wanger; John H Rex
Pharmacokinetic/pharmacodynamic modeling can help guide targeted antimicrobial therapy for nosocomial gram-negative infections in critically ill patients.
Diagnostic microbiology and infectious disease 2004;48(2):125-30.
2004: Peter G Pappas; John H Rex; Jack D Sobel; Scott Filler; William E Dismukes; THOMAS WALSH; John Edwards
Guidelines for treatment of candidiasis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(2):161-89.
2003: Luis Ostrosky-Zeichner; A M L Oude Lashof; Bart Jan Kullberg; John H Rex
Voriconazole salvage treatment of invasive candidiasis.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2003;22(11):651-5.
2003: Luis Ostrosky-Zeichner; John H Rex; Peter G Pappas; Richard J Hamill; Robert A Larsen; Harold W Horowitz; William G Powderly; Newton Hyslop; Carol A Kauffman; John Cleary; Julie E Mangino; Jeannette Lee
Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.
Antimicrobial agents and chemotherapy 2003;47(10):3149-54.
2003: Peter G Pappas; John H Rex; Jeannette Lee; Richard J Hamill; Robert A Larsen; William G Powderly; Carol A Kauffman; Newton Hyslop; Julie E Mangino; Stanley Chapman; Harold W Horowitz; John Edwards; William E Dismukes
A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(5):634-43.
2003: Zekaver Odabasi; Victor L Paetznick; Beth P Goldstein; John H Rex; Luis Ostrosky-Zeichner
Disk diffusion-based methods for determining Candida parapsilosis susceptibility to anidulafungin.
Antimicrobial agents and chemotherapy 2003;47(9):3018-20.
2003: Luis Ostrosky-Zeichner; Kieren Marr; John H Rex; Stuart H Cohen
Amphotericin B: time for a new "gold standard".
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(3):415-25.
2003: Madonna J Matar; Luis Ostrosky-Zeichner; Victor L Paetznick; Jose R Rodriguez; Enuo Chen; John H Rex
Correlation between E-test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole.
Antimicrobial agents and chemotherapy 2003;47(5):1647-51.
2003: Elias J Anaissie; Shawna L Stratton; M Cecilia Dignani; Choon-Kee Lee; Richard C Summerbell; John H Rex; Thomas P Monson; THOMAS WALSH
Pathogenic molds (including Aspergillus species) in hospital water distribution systems: a 3-year prospective study and clinical implications for patients with hematologic malignancies.
Blood 2003;101(7):2542-6.
2003: Banu Sancak; John H Rex; Victor L Paetznick; Enuo Chen; Jose Rodriguez
Evaluation of a method for identification of Candida dubliniensis bloodstream isolates.
Journal of clinical microbiology 2003;41(1):489-91.
2002: Luis Ostrosky-Zeichner; John H Rex; JOHN BENNETT; Bart Jan Kullberg
Deeply invasive candidiasis.
Infectious disease clinics of North America 2002;16(4):821-35.
2002: Elias J Anaissie; Shawna L Stratton; M Cecilia Dignani; Choon-Kee Lee; tahsine Mahfouz; John H Rex; Richard C Summerbell; THOMAS WALSH
Cleaning patient shower facilities: a novel approach to reducing patient exposure to aerosolized Aspergillus species and other opportunistic molds.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;35(8):E86-8.
2002: John H Rex; Michael A Pfaller
Has antifungal susceptibility testing come of age?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;35(8):982-9.
2002: Niki I Paphitou; Luis Ostrosky-Zeichner; Victor L Paetznick; Jose R Rodriguez; Enuo Chen; John H Rex
In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results.
Antimicrobial agents and chemotherapy 2002;46(10):3298-300.
2002: Sevtap Arikan; Victor L Paetznick; John H Rex
Comparative evaluation of disk diffusion with microdilution assay in susceptibility testing of caspofungin against Aspergillus and Fusarium isolates.
Antimicrobial agents and chemotherapy 2002;46(9):3084-7.
2002: Sevtap Arikan; John H Rex
New agents for the treatment of systemic fungal infections--current status.
Expert opinion on emerging drugs 2002;7(1):3-32.
2002: Sevtap Arikan; John H Rex
Ravuconazole Eisai/Bristol-Myers Squibb.
Current opinion in investigational drugs (London, England : 2000) 2002;3(4):555-61.
2002: Sevtap Arikan; Luis Ostrosky-Zeichner; Mario Lozano-Chiu; Victor L Paetznick; David Gordon; Tom Wallace; John H Rex
In vitro activity of nystatin compared with those of liposomal nystatin, amphotericin B, and fluconazole against clinical Candida isolates.
Journal of clinical microbiology 2002;40(4):1406-12.
2002: Niki I Paphitou; Luis Ostrosky-Zeichner; Victor L Paetznick; Jose R Rodriguez; Enuo Chen; John H Rex
In vitro antifungal susceptibilities of Trichosporon species.
Antimicrobial agents and chemotherapy 2002;46(4):1144-6.
2002: Elias J Anaissie; Shawna L Stratton; M Cecilia Dignani; Richard C Summerbell; John H Rex; Thomas P Monson; Horace Spencer; Miki Kasai; Andrea Francesconi; THOMAS WALSH
Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(6):780-9.
2002: Sevtap Arikan; Mario Lozano-Chiu; Victor L Paetznick; John H Rex
In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.
Antimicrobial agents and chemotherapy 2002;46(1):245-7.
2002: S Ascioglu; John H Rex; Ben E de Pauw; JOHN BENNETT; J Bille; F Crokaert; David W Denning; J Peter Donnelly; John Edwards; Z Erjavec; D Fiere; Olivier Lortholary; Johan Maertens; Jacques Meis; Thomas Patterson; J Ritter; Dominik Selleslag; P M Shah; D A Stevens; THOMAS WALSH
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(1):7-14.
2001: Elias J Anaissie; R T Kuchar; John H Rex; Andrea Francesconi; Miki Kasai; Frank-Michael C Müller; Mario Lozano-Chiu; Richard C Summerbell; M Cecilia Dignani; STEPHEN CHANOCK; THOMAS WALSH
Fusariosis associated with pathogenic fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33(11):1871-8.
2001: John H Rex; Michael A Pfaller; THOMAS WALSH; V Chaturvedi; Ana Espinel-Ingroff; Mahmoud A Ghannoum; L L Gosey; F C Odds; Michael G Rinaldi; Daniel J Sheehan; D W Warnock
Antifungal susceptibility testing: practical aspects and current challenges.
Clinical microbiology reviews 2001;14(4):643-58, table of contents.
2001: Luis Ostrosky-Zeichner; S Bazemore; Victor L Paetznick; Jose R Rodriguez; Enuo Chen; Tom Wallace; PA Cossum; John H Rex
Differential antifungal activity of isomeric forms of nystatin.
Antimicrobial agents and chemotherapy 2001;45(10):2781-6.
2001: John H Rex; THOMAS WALSH; Mary D Nettleman; Elias J Anaissie; JOHN BENNETT; E J Bow; A J Carillo-Munoz; Pascal Chavanet; Gretchen A Cloud; D W Denning; B E de Pauw; J E Edwards Jr; John W Hiemenz; Carol A Kauffman; G Lopez-Berestein; P Martino; Jack D Sobel; David A Stevens; R Sylvester; J Tollemar; C Viscoli; M A Viviani; T Wu
Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33(1):95-106.
2001: Omrum Uzun; S Ascioglu; E J Anaissie; John H Rex
Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32(12):1713-7.
2001: John H Rex; Jack D Sobel
Prophylactic antifungal therapy in the intensive care unit.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32(8):1191-200.
2001: Sevtap Arikan; John H Rex
Nystatin LF (Aronex/Abbott).
Current opinion in investigational drugs (London, England : 2000) 2001;2(4):488-95.
2001: Cherylyn A Savary; M L Grazziuti; Donna Przepiorka; S P Tomasovic; Bradley W McIntyre; Darren G Woodside; Neal R Pellis; Duane L Pierson; John H Rex
Characteristics of human dendritic cells generated in a microgravity analog culture system.
In vitro cellular & developmental biology. Animal 2001;37(4):216-22.
2001: Monica Grazziutti; Donna Przepiorka; John H Rex; Ira Braunschweig; Saroj Vadhan-Raj; Cherylyn A Savary
Dendritic cell-mediated stimulation of the in vitro lymphocyte response to Aspergillus.
Bone marrow transplantation 2001;27(6):647-52.
2001: John H Rex; THOMAS WALSH; Jack D Sobel; Scott Filler; Peter G Pappas; William E Dismukes; John Edwards
Reply to Dr. Chandrasekar (Clin Infect Dis 2001; 32:320-1) and Drs. Marr and Boeckh (Clin Infect Dis 2001; 32:321).
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32(3):518-9.
2001: Sevtap Arikan; Mario Lozano-Chiu; Victor L Paetznick; John H Rex
In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates.
Antimicrobial agents and chemotherapy 2001;45(1):327-30.
2000: John H Rex; THOMAS WALSH; Jack D Sobel; Scott Filler; Peter G Pappas; William E Dismukes; John Edwards
Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(4):662-78.
2000: Karl V Clemons; Vera Calich; Eva Burger; Scott Filler; Monica Grazziutti; J Murphy; Emmanuel Roilides; Ana Campa; M R Dias; John Edwards; Y Fu; G Fernandes-Bordignon; A Ibrahim; H Katsifa; Cristina Gil Lamaignere; LH Meloni-Bruneri; John H Rex; Cherylyn A Savary; CF Xidieh
Pathogenesis I: interactions of host cells and fungi.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2000;38 Suppl 1():99-111.
1999: Sevtap Arikan; Mario Lozano-Chiu; Victor L Paetznick; S Nangia; John H Rex
Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species.
Journal of clinical microbiology 1999;37(12):3946-51.
1999: Mario Lozano-Chiu; Sevtap Arikan; Victor L Paetznick; Elias J Anaissie; John H Rex
Optimizing voriconazole susceptibility testing of Candida: effects of incubation time, endpoint rule, species of Candida, and level of fluconazole susceptibility.
Journal of clinical microbiology 1999;37(9):2755-9.
1999: Mario Lozano-Chiu; PW Nelson; Victor L Paetznick; John H Rex
Disk diffusion method for determining susceptibilities of Candida spp. to MK-0991.
Journal of clinical microbiology 1999;37(5):1625-7.
1999: Mario Lozano-Chiu; Sevtap Arikan; Victor L Paetznick; Elias J Anaissie; D Loebenberg; John H Rex
Treatment of murine fusariosis with SCH 56592.
Antimicrobial agents and chemotherapy 1999;43(3):589-91.
1998: MD Martins; Mario Lozano-Chiu; John H Rex
Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;27(5):1291-4.
1998: MD Martins; L J Rodriguez; Cherylyn A Savary; Monica Grazziutti; D Deshpande; DM Cohen; Richard E Cowart; Darren G Woodside; Bradley W McIntyre; Elias J Anaissie; John H Rex
Activated lymphocytes reduce adherence of Aspergillus fumigatus.
Medical mycology : official publication of the International Society for Human and Animal Mycology 1998;36(5):281-9.
1998: Mario Lozano-Chiu; Victor L Paetznick; Mahmoud A Ghannoum; John H Rex
Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: performances of three different media assessed by using E-test and National Committee for Clinical Laboratory Standards M27-A methodologies.
Journal of clinical microbiology 1998;36(10):2817-22.
1998: Michael A Pfaller; Sevtap Arikan; Mario Lozano-Chiu; Y Chen; Stacy Coffman; Shawn A Messer; Robert P Rennie; Crystal Sand; T Heffner; John H Rex; J Wang; N Yamane
Clinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testing.
Journal of clinical microbiology 1998;36(9):2609-12.
1998: Mario Lozano-Chiu; MV Lancaster; John H Rex
Evaluation of a colorimetric method for detecting amphotericin B-resistant Candida isolates.
Diagnostic microbiology and infectious disease 1998;31(3):417-24.
1998: L J Rodriguez-Adrian; Monica Grazziutti; John H Rex; Elias J Anaissie
The potential role of cytokine therapy for fungal infections in patients with cancer: is recovery from neutropenia all that is needed?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;26(6):1270-8.
1998: E J Anaissie; John H Rex; O Uzun; SE Vartivarian
Predictors of adverse outcome in cancer patients with candidemia.
The American journal of medicine 1998;104(3):238-45.
1998: Frank C Odds; Frans Van Gerven; Ana Espinel-Ingroff; M S Bartlett; Mahmoud A Ghannoum; MV Lancaster; Michael A Pfaller; John H Rex; Michael G Rinaldi; THOMAS WALSH
Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models.
Antimicrobial agents and chemotherapy 1998;42(2):282-8.
1998: Emmanuel Roilides; M Cecilia Dignani; Elias J Anaissie; John H Rex
The role of immunoreconstitution in the management of refractory opportunistic fungal infections.
Medical mycology : official publication of the International Society for Human and Animal Mycology 1998;36 Suppl 1():12-25.
1998: John H Rex; THOMAS WALSH; Elias J Anaissie
Fungal infections in iatrogenically compromised hosts.
Advances in internal medicine 1998;43():321-71.
1998: John H Rex; PW Nelson; Victor L Paetznick; Mario Lozano-Chiu; Ana Espinel-Ingroff; Elias J Anaissie
Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis.
Antimicrobial agents and chemotherapy 1998;42(1):129-34.
1998: Cherylyn A Savary; Monica Grazziutti; Bohuslav Melichar; Donna Przepiorka; Ralph S Freedman; Richard E Cowart; DM Cohen; Elias J Anaissie; Darren G Woodside; Bradley W McIntyre; Duane L Pierson; Neal R Pellis; John H Rex
Multidimensional flow-cytometric analysis of dendritic cells in peripheral blood of normal donors and cancer patients.
Cancer immunology, immunotherapy : CII 1998;45(5):234-40.
1997: Monica Grazziutti; John H Rex; Richard E Cowart; Elias J Anaissie; A Ford; Cherylyn A Savary
Aspergillus fumigatus conidia induce a Th1-type cytokine response.
The Journal of infectious diseases 1997;176(6):1579-83.
1997: MD Martins; Mario Lozano-Chiu; John H Rex
Point prevalence of oropharyngeal carriage of fluconazole-resistant Candida in human immunodeficiency virus-infected patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;25(4):843-6.
1997: Tom Wallace; V Paetznick; PA Cossum; G Lopez-Berestein; John H Rex; E Anaissie
Activity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic mice.
Antimicrobial agents and chemotherapy 1997;41(10):2238-43.
1997: M Cecilia Dignani; Elias J Anaissie; Jeane Hester; Susan O'Brien; SE Vartivarian; John H Rex; Andrew Lamb; David Jendiroba; Benjamin Lichtiger; Borje S Andersson; Emil J Freireich
Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study.
Leukemia 1997;11(10):1621-30.
1997: PW Nelson; Mario Lozano-Chiu; John H Rex
In vitro growth-inhibitory activity of pneumocandins L-733,560 and L-743,872 against putatively amphotericin B- and fluconazole-resistant Candida isolates: influence of assay conditions.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1997;35(4):285-7.
1997: Michael A Pfaller; John H Rex; Michael G Rinaldi
Antifungal susceptibility testing: technical advances and potential clinical applications.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(5):776-84.
1997: DM Cohen; S C Bhalla; Elias J Anaissie; Jeane Hester; Cherylyn A Savary; John H Rex
Effects of in vitro and in vivo cytokine treatment, leucapheresis and irradiation on the function of human neutrophils: implications for white blood cell transfusion therapy.
Clinical and laboratory haematology 1997;19(1):39-47.
1997: M D Martins; John H Rex
Fluconazole suspension for oropharyngeal candidiasis unresponsive to tablets.
Annals of internal medicine 1997;126(4):332-3.
1997: John H Rex; Michael A Pfaller; John N Galgiani; M S Bartlett; Ana Espinel-Ingroff; Mahmoud A Ghannoum; MV Lancaster; Frank C Odds; Michael G Rinaldi; THOMAS WALSH; Arthur L Barry
Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(2):235-47.
1997: Mario Lozano-Chiu; PW Nelson; MV Lancaster; Michael A Pfaller; John H Rex
Lot-to-lot variability of antibiotic medium 3 used for testing susceptibility of Candida isolates to amphotericin B.
Journal of clinical microbiology 1997;35(1):270-2.
1997: Ana Espinel-Ingroff; M Bartlett; R Bowden; Nai Xun Chin; C Cooper; AW Fothergill; Michael R McGinnis; P Menezes; Shawn A Messer; PW Nelson; Frank C Odds; Lester Pasarell; J Peter; Michael A Pfaller; John H Rex; Michael G Rinaldi; Gillian Shankland; THOMAS WALSH; I Weitzman
Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi.
Journal of clinical microbiology 1997;35(1):139-43.
1997: L J Rodriguez; John H Rex; Elias J Anaissie
Update on invasive candidiasis.
Advances in pharmacology (San Diego, Calif.) 1997;37():349-400.
1996: Elias J Anaissie; Victor L Paetznick; L G Ensign; Ana Espinel-Ingroff; John N Galgiani; C A Hitchcock; M LaRocco; Thomas Patterson; Michael A Pfaller; John H Rex; M G Rinaldi
Microdilution antifungal susceptibility testing of Candida albicans and Cryptococcus neoformans with and without agitation: an eight-center collaborative study.
Antimicrobial agents and chemotherapy 1996;40(10):2387-91.
1996: M D Martins; John H Rex
Resistance to antifungal agents in the critical care setting: problems and perspectives.
New horizons (Baltimore, Md.) 1996;4(3):338-44.
1996: Michael A Pfaller; S A Messer; A Bolmström; F C Odds; John H Rex
Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates.
Journal of clinical microbiology 1996;34(7):1691-3.
1996: John H Rex; Michael A Pfaller; MV Lancaster; F C Odds; A Bolmström; M G Rinaldi
Quality control guidelines for National Committee for Clinical Laboratory Standards--recommended broth macrodilution testing of ketoconazole and itraconazole.
Journal of clinical microbiology 1996;34(4):816-7.
1996: M A Ghannoum; John H Rex; John N Galgiani
Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome.
Journal of clinical microbiology 1996;34(3):489-95.
1996: N N Vanek; S Kazi; N M Cepero; S Tang; John H Rex
Human ehrlichiosis causing left ventricular dilatation and dysfunction.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;22(2):386-7.
1995: Michael A Pfaller; J Rhine-Chalberg; A L Barry; John H Rex
Strain variation and antifungal susceptibility among bloodstream isolates of Candida species from 21 different medical institutions.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21(6):1507-9.
1995: A Wanger; K Mills; PW Nelson; John H Rex
Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates.
Antimicrobial agents and chemotherapy 1995;39(11):2520-2.
1995: John H Rex; JOHN BENNETT; A M Sugar; P G Pappas; Jonathan S Serody; John Edwards; R G Washburn
Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21(4):994-6.
1995: John H Rex; S C Bhalla; D M Cohen; Jeane Hester; SE Vartivarian; Elias J Anaissie
Protection of human polymorphonuclear leukocyte function from the deleterious effects of isolation, irradiation, and storage by interferon-gamma and granulocyte-colony-stimulating factor.
Transfusion 1995;35(7):605-11.
1995: Michael A Pfaller; M Bale; B Buschelman; M Lancaster; Ana Espinel-Ingroff; John H Rex; Michael G Rinaldi; C R Cooper; M R McGinnis
Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine.
Journal of clinical microbiology 1995;33(5):1104-7.
1995: John H Rex; C R Cooper; William G Merz; John N Galgiani; Elias J Anaissie
Detection of amphotericin B-resistant Candida isolates in a broth-based system.
Antimicrobial agents and chemotherapy 1995;39(4):906-9.
1995: John H Rex; Michael A Pfaller; A L Barry; PW Nelson; C D Webb
Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group.
Antimicrobial agents and chemotherapy 1995;39(1):40-4.
1995: John H Rex; M G Rinaldi; Michael A Pfaller
Resistance of Candida species to fluconazole.
Antimicrobial agents and chemotherapy 1995;39(1):1-8.
1994: John H Rex; JOHN BENNETT; A M Sugar; P G Pappas; Charles van der Horst; John Edwards; R G Washburn; W M Scheld; A W Karchmer; A P Dine
A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute.
The New England journal of medicine 1994;331(20):1325-30.
1994: Elias J Anaissie; N C Karyotakis; Ray Hachem; M Cecilia Dignani; John H Rex; Victor L Paetznick
Correlation between in vitro and in vivo activity of antifungal agents against Candida species.
The Journal of infectious diseases 1994;170(2):384-9.
1994: Pablo C Okhuysen; John H Rex; M Kapusta; C Fife
Successful treatment of extensive posttraumatic soft-tissue and renal infections due to Apophysomyces elegans.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;19(2):329-31.
1994: Michael A Pfaller; M Bale; B Buschelman; M Lancaster; Ana Espinel-Ingroff; John H Rex; Michael G Rinaldi
Selection of candidate quality control isolates and tentative quality control ranges for in vitro susceptibility testing of yeast isolates by National Committee for Clinical Laboratory Standards proposed standard methods.
Journal of clinical microbiology 1994;32(7):1650-3.
1994: Michael A Pfaller; B Buschelman; M J Bale; M Lancaster; Ana Espinel-Ingroff; John H Rex; Michael G Rinaldi
Multicenter comparison of a colorimetric microdilution broth method with the reference macrodilution method for in vitro susceptibility testing of yeast isolates.
Diagnostic microbiology and infectious disease 1994;19(1):9-13.